Day: February 1, 2022

Clover Appoints Nicholas Jackson, Ph.D., as President of Global Research and Development

Written by Customer Service on February 1, 2022. Posted in Public Companies.

CHENGDU, China, Feb. 01, 2022 (GLOBE NEWSWIRE) — Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates, today announced the appointment of Nicholas Jackson, Ph.D., as President of Global Research and Development. Dr. Jackson will work closely with the Company’s CEO, Joshua Liang, to accelerate the development of Clover’s existing pipeline candidates and nominate new product candidates. “We are excited to welcome Nick to Clover’s leadership team. His extensive experience in leading vaccine and immunotherapeutic research and development will be invaluable as we continue to advance and expand our portfolio of innovative product candidates,” stated Joshua Liang, Chief Executive Officer of Clover Biopharmaceuticals....

New Rackspace Technology Report Finds AI/ML Technologies Increasingly Mission-Critical, But Full Benefits Have Yet to Be Realized

Written by Customer Service on February 1, 2022. Posted in Public Companies.

Skills, Data Quality and Lack of Organizational Buy-In Cited as Barriers; AI/ML Top IT Priority for Businesses, Alongside Cybersecurity SAN ANTONIO, Feb. 01, 2022 (GLOBE NEWSWIRE) — Rackspace Technology® (NASDAQ: RXT), a leading end-to-end, multicloud technology solutions company, today announced a new research report that finds that while Artificial Intellegence and Machine Learning (AI/ML) are on nearly every organization’s radar much work remains to be done to tap their full potential. Rackspace Technology polled 1,870 global IT leaders, across industries, including manufacturing, financial services, retail, government, and healthcare to understand the dynamics of AI/ML uptake. While 62% of respondents said that AI/ML is a high priority for their organization, and 70% of all respondents reported positive impacts of on...

ResMed Welcomes Urvashi Tyagi as New Chief Technology Officer

Written by Customer Service on February 1, 2022. Posted in Public Companies.

Urvashi Tyagi, ResMed Chief Technology OfficerUrvashi Tyagi, ResMed Chief Technology OfficerTyagi brings over 25 years’ IT and leadership experience from ADP, American Express, Amazon, Microsoft, and IBM Current CTO and SaaS President Bobby Ghoshal now transitions to SaaS full-timeSAN DIEGO, Feb. 01, 2022 (GLOBE NEWSWIRE) — ResMed (NYSE: RMD, ASX: RMD) today announced the appointment of Urvashi Tyagi as chief technology officer (CTO), effective today. As CTO, Tyagi will lead ResMed’s Digital Health Technology team, driving the innovation and adoption of its world-leading cloud-based digital health platforms, as well as investments in emerging technologies like artificial intelligence and machine learning. Tyagi has over 25 years’ experience in IT and mechanical engineering, user experience, finance, business...

SPYR Technologies Affiliate Applied Magix Introduces the MagixBlock USB DataBlocker as a Stand-Alone Product of Its Line of Totally Convenient™ Products

Written by Customer Service on February 1, 2022. Posted in Public Companies.

THE WOODLANDS, Texas, Feb. 01, 2022 (GLOBE NEWSWIRE) — via InvestorWire — SPYR, Inc. dba SPYR Technologies (OTCQB: SPYR) (https://spyr.com), a technology company whose subsidiary, Applied Magix, Inc., develops and resells Apple® ecosystem compatible products in the growing multibillion-dollar IoT smart home and connected car markets, introduces its MagixBlock USB DataBlocker product in a stand-alone package, combining both USB-A and USB-C versions in a single universal package. “While our customers primarily use the MagixBlock DataBlocker to prevent their car’s not-so-smart system from interfering with MagixDrive operations, many have asked to have MagixBlock made available separately,” said Applied Magix CEO Dr. Harald Zink. “This way our customers can use our exemplary product to protect their iOS devices while traveling.” “While...

Denali Therapeutics Announces Presentations on DNL310 (ETV:IDS) Development Program in MPS II (Hunter Syndrome) at the Upcoming WORLDSymposium™

Written by Customer Service on February 1, 2022. Posted in Public Companies.

SOUTH SAN FRANCISCO, Calif., Feb. 01, 2022 (GLOBE NEWSWIRE) — Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenerative diseases, today announced upcoming presentations from the DNL310 (ETV:IDS) clinical development program to be given at the 18th Annual WORLDSymposium™, which will be held February 7-11, 2022, in San Diego, California, and virtually. DNL310 is an investigational brain-penetrant enzyme replacement therapy intended to treat both central nervous system (CNS) and peripheral manifestations of MPS II (Hunter syndrome). An oral presentation will provide longer-term safety, biomarker (glycosaminoglycans and lysosomal lipids) and exploratory clinical data on Cohorts A and B from an ongoing...

Shineco, Inc. Appoints Professor Qiyin Sun as Chief Medical Consultant

Written by Customer Service on February 1, 2022. Posted in Public Companies.

BEIJING, Feb. 01, 2022 (GLOBE NEWSWIRE) — Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech products, announced that the Company has appointed Professor Qiyin Sun as the Chief Medical Consultant. Professor Sun will lead the research and innovation of the Company’s tumor treatment and provide technical consultation in early tumor screening and tumor radiotherapy to support the commercialization of digital tumor diagnosis and treatment. Prior to serving as the chief medical consultant at Shineco, Professor Sun was a director at Beijing Nuclear Medicine Equipment Engineering Technology Research Center and the winner of the second prize of China Science and Technology Progress Award. He played a crucial role in leading large-scale...

Life Clips, Inc. to Hold Virtual Annual Shareholders’ Meeting, Answer Shareholder Questions

Written by Customer Service on February 1, 2022. Posted in Public Companies.

AVENTURA, Fla., Feb. 01, 2022 (GLOBE NEWSWIRE) — Life Clips, Inc. (OTC Pink: LCLP) (the “Company”) today announced it will be holding its Annual Meeting of Shareholders in a virtual-only meeting format on Tuesday, March 29, 2022, at 4:30 PM EST. Information for accessing the meeting will be provided in a future announcement. The Company will not be soliciting any proxies, and there will be no voting at this annual meeting. The Company expects to file an Information Statement on Schedule 14C to announce the election of directors. Shareholders are encouraged to submit any questions they would like to have answered during the meeting to info@lifeclips.com by Tuesday, February 15, 2022. Questions will only be accepted from shareholders that appear on the Company’s shareholder list, list of non-objecting beneficial owners or that otherwise...

Lemongrass Grows Microsoft Azure Practice with Acquisition of Wharfedale Technologies

Written by Customer Service on February 1, 2022. Posted in Mergers And Acquisitions.

The purchase of company’s business and assets strengthens Lemongrass’s position as the preferred provider to Enterprises that want to run SAP systems in the cloud ATLANTA, Feb. 01, 2022 (GLOBE NEWSWIRE) — Lemongrass, the “SAP in the Cloud” company, announces the acquisition of the business and assets of Wharfedale Technologies (WFT), a technology services company specializing in the migration and management of SAP on Microsoft Azure. Due to demand from its customers, Lemongrass recently made the strategic decision to expand its cloud infrastructure portfolio to include other hyperscale platforms, including Azure. Microsoft is heavily investing in Azure and growing its SAP-specific automation capabilities – Lemongrass’s area of strength. Lemongrass recently announced that it has attained a Gold competency, demonstrating a “best-in-class”...

Sorrento Completes Acquisition of Virex Health, Will Commercialize Next-Generation at-Home Diagnostic Testing That Rivals PCR-Level Sensitivity for Daily Covid-19 Tests and Early Cancer Diagnosis

Written by Customer Service on February 1, 2022. Posted in Mergers And Acquisitions.

Virex Health, Inc. is a Boston, Massachusetts company that has developed a powerful, broadly applicable at-home diagnostic platform (“Virex Technology”). Virex Technology, invented and developed by Boston University (BU) Professors Mark Grinstaff and Scott Schaus and Virex scientists, employs widely used electrochemistry found in household diabetes glucometer devices for next generation diagnostics. Virex Technology has demonstrated extremely high sensitivity for multiple biological analytes including COVID-19 virus detection as sensitive as 10 TCID50, rivalling PCR sensitivity. Virex’s early liver cancer biomarker test detects a liver cancer biomarker in as little as 2 microliters of blood. Virex’s diagnostic tests provide qualitative and/or quantitative results in as little as 5 minutes. Virex’s diagnostic tests leverage existing worldwide...

Stand-up Pouches Market to Worth USD 20.12 Billion by 2026 | Stand-up Pouches Industry Trends, Growth, Share, and Forecast Report by Fortune Business Insights

Written by Customer Service on February 1, 2022. Posted in Mergers And Acquisitions.

Key companies covered in stand-up pouches market are Sonoco Products Company, ProAmpac, Berry Global, Inc., Amcor, Sealed Air Corporation, Bemis Company, Inc., Coveris Group, Huhtamaki, and more players profiled Pune, Feb. 01, 2022 (GLOBE NEWSWIRE) — The global stand-up pouches market size is expected to gain momentum exhibiting a CAGR of 7.73% between 2019 and 2026. Factors such as increasing demand for sustainable packaging and rising preference for packaged food products is likely to propel the market growth during the forecast period. The reports further mention that the market was worth USD 11.13 billion in 2018 and is projected to reach USD 20.12 billion by 2026. Stand-up pouches have a long dating history as Louis Doyen, the CEO of Thimonnier, the French machine manufacturing company invented them in 1963. They are typically...

Day: February 1, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice